Phase II study of IRInotecan treatment after COmbined chemo-immunotherapy for extensive-stage small cell lung cancer: Protocol of IRICO study.
Hiromi TomonoHirokazu TaniguchiMinoru FukudaTakaya IkedaSeiji NagashimaKazumasa AkagiSawana OnoYasuhiro UmeyamaMidori ShimadaHiroshi GyotokuShinnosuke TakemotoYasushi HisamatsuRyotaro MorinagaRyuta TagawaRyosuke OgataYosuke DotsuHiroaki SenjuHiroshi SodaKatsumi NakatomiFumiko HayashiNanae SugasakiAkitoshi KinoshitaHiroshi MukaePublished in: Thoracic cancer (2023)
This study was registered in the Japan Registry of Clinical Trials (no. jRCT s071210090) on November 4, 2021.